StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) stock

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3090% above fair value
$294.55−0.48 (-0.16%)

Close on Nov 16, 2026Market cap $520.50BP/E 83.2Yield 2.26%

AbbVie price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

AbbVie's price to sales ratio was 8.1× on Nov 11, 2026, against 6.8× a year earlier. Over the last 5 years it ranged from 4.2× to 8.1×, with a median of 5.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20268.1×+1.3
2025Dec 31, 20256.8×+1.1
2024Dec 31, 20245.7×+0.7
2023Dec 29, 20235.0×+0.0
2022Dec 30, 20225.0×+0.6
2021Dec 31, 20214.4×+0.1
2020Dec 31, 20204.2×+0.2
2019Dec 31, 20194.0×−0.5
2018Dec 31, 20184.5×−1.2
2017Dec 29, 20175.7×+1.6
2016Dec 30, 20164.1×−0.3
2015Dec 31, 20154.4×−1.0
2014Dec 31, 20145.4×+0.9
2013Dec 31, 20134.5×–

More AbbVie figures

See a number that looks wrong?